Search results
Studies show narcolepsy is a risk factor for cardiovascular disease and adverse cardiac events
Medical Xpress· 10 hours agoResults show that people who have narcolepsy, compared with those without narcolepsy, had a 77% increased risk of any cardiovascular disease and an 82% ...
Takeda's TAK-861 shows promise in narcolepsy trial By Investing.com
Investing.com· 10 hours agoThe trial demonstrated statistically significant improvements in sleep latency and reductions in...
NLS reports narcolepsy treatment progress at ASCP By Investing.com
Investing.com· 6 days agoZÜRICH - NLS Pharmaceutics Ltd. (NASDAQ:NLSP), a Swiss biopharmaceutical company, has announced...
NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects...
Digital Journal· 7 days ago"These data underscore our continued commitment to advancing our pipeline which has the potential to change the treatment paradigm for patients impacted by sleep and wakefulness ...
Is Oversleeping Bad? Potential Causes and Side Effects (Including Weight Gain)
MediaFeed via AOL· 16 hours agoWhile you may not remember these interruptions, they do a number on your sleep quality. In this way,...
J&J antidepressant eases symptoms, improves sleep in key trial
BioPharma Dive via Yahoo Finance· 6 days agoJ&J is studying the drug, called seltorexant, as an “adjunctive” therapy to background treatment...
7 Overlooked Stocks Offering Long-Term Stability From the Shadows
InvestorPlace· 9 hours agoWhile you can screen for micro-caps, pink sheet stocks, and similar speculative investments, most of...
Alkermes to Participate in Two Upcoming Investor Conferences
WPRI Providence· 5 days agoThe company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline ...
What Raises the Risk for Early Puberty in Girls?
Medscape· 5 days agoIn Chinese girls, a mix of overweight/obesity, limited physical activity, and excessive screen time raised the risk for EPD, with excess weight alone or...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 7 days agoHAMILTON, BERMUDA / May 28, 2024 / Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets ...